Simon Cote is a principal engineer, Technical Customer Services, West Pharmaceutical Services, Inc.

Simon Cote

Drug product and parenteral packaging component manufacturers are continuously evolving in alignment with the advancements in technology and increasing regulatory requirements to better ensure the quality and safety of injectable drug products for patients. The incorporation of barrier technology and flexible fillers and the use of ready-to-use (RTU) packaging components are rapidly gaining adoption as safe and effective solutions for fill/finish processes and container closure systems, respectively. 

Pharmaceutical Technology’s Biologics and Sterile Drug Manufacturing 2018

 Biologics and Sterile Drug Manufacturing 

	When referring to this article, please cite it as S. Cote, “Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements,” 

Pharmaceutical Technology Biologics and Sterile Drug Manufacturing 

Articles

Ready-to-use components eliminate the need for component preparation by the drug product manufacturer, enabling them to streamline their processes and focus on their core competencies, such as drug product development and manufacturing.